ArticleNeuropsychiatric disease and treatment2021

The Effect of Viloxazine Extended-Release Capsules on Functional Impairments Associated with Attention-Deficit/Hyperactivity Disorder (ADHD) in Children and Adolescents in Four Phase 3 Placebo-Controlled Trials.

Azmi Nasser et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.